The results of this study revealed that FV treatment can commendably ameliorate lipid metabolism and hepatic inflammation by regulating CD36 and alleviate the progression of NAFLD by regulating the composition and potential function of the gut microbiota. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.